Search results
Navigating Alzheimer's care: The promises and limits of a new drug
KPBS San Diego· 1 day agoAlzheimer's Disease and related dementias take a heavy toll on individuals and their caregivers. New...
TIME100 Health: David Ricks
Time via Yahoo Finance· 8 hours agoRicks is waiting for a decision from the FDA about its Alzheimer’s drug donanemab, a call the agency delayed this spring, citing the ...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 10 hours agoTwo of them -- donanemab and mirikuzumab -- already await regulatory approval. The U.S. Food and Drug Administration (FDA) plans to convene an advisory...
Women are reporting bizarre 'Ozempic breast' side effect that's stunned doctors
The US Sun· 7 hours agoFROM floppy bums to sunken cheeks, drugs like Ozempic and Wegovy have been linked to some bizarre...
Alzheimer's moves faster in people with Down syndrome
Futurity· 7 days agoNearly all adults with Down syndrome will develop evidence of Alzheimer’s disease by late middle...
Baptist Health offering new infusion treatment for those in early stages of Alzheimer's
KATV Little Rock· 3 days agoIn a 18-month long study, intravenous (IV) infusion treatment with LEQEMBI (Lecanemab) was proven to slow the progress of early Alzheimer's disease. People ...
TIME100 Health: Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst
Time via Yahoo News· 8 hours agoMojsov, a chemist two floors away, also independently identified the active portion of GLP-1, which...
To save lives, the FDA must change how it evaluates rare disease treatments
Salon via Yahoo News· 1 day agoThat's not necessarily because scientists and clinicians don't know how to treat them. It's because...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance via AOL· 3 days agoIn March, Novo's Wegovy was approved by the FDA for those with cardiovascular disease and risk of...
